REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $229,000 | -42.2% | 7,072 | -26.8% | 0.01% | 0.0% |
| Q4 2019 | $396,000 | +19.3% | 9,661 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $332,000 | -31.7% | 9,661 | +2.2% | 0.01% | -35.0% |
| Q2 2019 | $486,000 | -1.0% | 9,452 | +10.4% | 0.02% | -9.1% |
| Q1 2019 | $491,000 | +36.8% | 8,564 | 0.0% | 0.02% | +37.5% |
| Q4 2018 | $359,000 | -67.9% | 8,564 | -42.1% | 0.02% | -72.9% |
| Q3 2018 | $1,117,000 | +5.3% | 14,789 | 0.0% | 0.06% | -33.0% |
| Q2 2018 | $1,061,000 | +56.0% | 14,789 | -35.1% | 0.09% | -2.2% |
| Q1 2018 | $680,000 | -11.8% | 22,789 | -1.8% | 0.09% | -17.4% |
| Q4 2017 | $771,000 | – | 23,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |